Mesenchymal soluble factors confer imatinib drug resistance in chronic myelogenous leukemia cells

Detalles Bibliográficos
Autores principales: Regev, Ofer, Kidan, Noa, Nicola, Meshel, Khamisie, Hazem, Ruthardt, Martin, Mahajna, Jamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811319/
https://www.ncbi.nlm.nih.gov/pubmed/33488882
http://dx.doi.org/10.5114/aoms.2020.101042
_version_ 1783637473122844672
author Regev, Ofer
Kidan, Noa
Nicola, Meshel
Khamisie, Hazem
Ruthardt, Martin
Mahajna, Jamal
author_facet Regev, Ofer
Kidan, Noa
Nicola, Meshel
Khamisie, Hazem
Ruthardt, Martin
Mahajna, Jamal
author_sort Regev, Ofer
collection PubMed
description
format Online
Article
Text
id pubmed-7811319
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-78113192021-01-22 Mesenchymal soluble factors confer imatinib drug resistance in chronic myelogenous leukemia cells Regev, Ofer Kidan, Noa Nicola, Meshel Khamisie, Hazem Ruthardt, Martin Mahajna, Jamal Arch Med Sci Letter to the Editor Termedia Publishing House 2020-11-20 /pmc/articles/PMC7811319/ /pubmed/33488882 http://dx.doi.org/10.5114/aoms.2020.101042 Text en Copyright: © 2020 Termedia & Banach http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Letter to the Editor
Regev, Ofer
Kidan, Noa
Nicola, Meshel
Khamisie, Hazem
Ruthardt, Martin
Mahajna, Jamal
Mesenchymal soluble factors confer imatinib drug resistance in chronic myelogenous leukemia cells
title Mesenchymal soluble factors confer imatinib drug resistance in chronic myelogenous leukemia cells
title_full Mesenchymal soluble factors confer imatinib drug resistance in chronic myelogenous leukemia cells
title_fullStr Mesenchymal soluble factors confer imatinib drug resistance in chronic myelogenous leukemia cells
title_full_unstemmed Mesenchymal soluble factors confer imatinib drug resistance in chronic myelogenous leukemia cells
title_short Mesenchymal soluble factors confer imatinib drug resistance in chronic myelogenous leukemia cells
title_sort mesenchymal soluble factors confer imatinib drug resistance in chronic myelogenous leukemia cells
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811319/
https://www.ncbi.nlm.nih.gov/pubmed/33488882
http://dx.doi.org/10.5114/aoms.2020.101042
work_keys_str_mv AT regevofer mesenchymalsolublefactorsconferimatinibdrugresistanceinchronicmyelogenousleukemiacells
AT kidannoa mesenchymalsolublefactorsconferimatinibdrugresistanceinchronicmyelogenousleukemiacells
AT nicolameshel mesenchymalsolublefactorsconferimatinibdrugresistanceinchronicmyelogenousleukemiacells
AT khamisiehazem mesenchymalsolublefactorsconferimatinibdrugresistanceinchronicmyelogenousleukemiacells
AT ruthardtmartin mesenchymalsolublefactorsconferimatinibdrugresistanceinchronicmyelogenousleukemiacells
AT mahajnajamal mesenchymalsolublefactorsconferimatinibdrugresistanceinchronicmyelogenousleukemiacells

Ejemplares similares